Supriya Gupta, MD
@SupriyaGuptaMD
Followers
147
Following
179
Media
20
Statuses
94
Asst. Professor @UMNHOT @UMNCancer via @MayoClinic | @WomenInLymphoma | #CARTcell #lymsm | Opinions my own
Minneapolis, MN
Joined August 2022
Excellent news for our CAR-T patients! The FDA has relaxed the post-infusion monitoring requirement near the treatment center and driving restrictions down to 2 weeks. This change reflects growing safety data with CAR-T!. #lymsm #mmsm #leuksm
fda.gov
The REMS for currently approved BCMA- and CD19-directed autologous chimeric antigen receptor (CAR) T cell immunotherapies have been eliminated because the FDA has determined that a REMS is no longer...
0
1
11
RT @YiLinMDPhD: Happening now #EHA25 poster session. Dr. Melinda Tan @MayoCancerCare presents cytokine and cellular immune profile distinct….
0
3
0
RT @OncLive: On May 8, the @US_FDA lifted a clincal hold on an active IND application for the tabelecleucel, allowing the resumption of cli….
onclive.com
FDA lifts clinical hold on tabelecleucel IND, enabling trial resumption in EBV+ PTLD following HSCT or SOT in relapsed/refractory patients.
0
2
0
Had a great time presenting our research on cytokine trends as #biomarkers to predict the development of post CAR-T hyperinflammatory states and guide treatment. Exciting discussion and collaboration ahead! Grateful for the incredible mentorship of @YiLinMDPhD .#Tandem25 @ASTCT
1
3
18
RT @WomenInLymphoma: ⚕️ @WomenInLymphoma Steering Committee members, advocates, sponsors and supporters from all over the world🌍networking….
0
13
0
RT @NEJM: In patients with advanced-stage Hodgkin’s lymphoma, nivolumab added to chemotherapy resulted in greater 2-year progression-free s….
0
48
0
RT @marrowonthemove: Doctors at the University of Minnesota Adult Blood and Marrow Transplant and Cellular Therapy Program (BMTCT) Program….
0
1
0
RT @BloodAdvances: Patients excluded from clinical trials of DLBCL are at a higher risk of dying from lymphoma when treated with standard-o….
0
8
0
RT @WomenInLymphoma: Congratulations and welcome to WiL's new *Sub-Committee Emerging Collaborators* 🌏🩺.@AllisonBarra1 @OncDocBock @Supriy….
0
9
0
RT @BloodJournal: Glofitamab stimulates immune cell infiltration of CNS tumors and induces clinical responses in secondary CNS lymphoma.htt….
ashpublications.org
Godfrey and colleagues report the first case series of patients with central nervous system (CNS) lymphoma treated with CD3-CD20 bispecific-based therapy.
0
7
0
RT @VincentRK: Cure is a simple word. But there is confusion when it comes to cancer. What cure is in cancer, and what we should aspire for….
0
57
0
Learn about the effects of donor chimerism after allogeneic SCT and #PTCy with Dr. Graham at the Oral Abstract session on stem cell transplant at EHA2024 today! #BMTsm.
Come join me at 1630 CEST or 930 CST at Goya 1 at #EHA2024 at the Stem Cell- Transplant 2 to see me discuss how mixed donor chimerism after transplant affects relapse after PTCy. @MayoTransplant @MayoHemeOnc @MayoCancerCare #bmtsm #ptcy.
0
0
2
RT @ChrisGrahamMD: Come join me at 1630 CEST or 930 CST at Goya 1 at #EHA2024 at the Stem Cell- Transplant 2 to see me discuss how mixed do….
0
1
0
RT @OncLive: The FDA has granted accelerated approval to lisocabtagene maraleucel for the treatment of select adult patients with relapsed….
onclive.com
The FDA has granted accelerated approval to lisocabtagene maraleucel for the treatment of select adult patients with relapsed or refractory follicular lymphoma.
0
2
0
RT @HadidiSamer: #mmsm .How to counsel patients about Cilta Cel using the data from.CARTITUDE-4 and FDA ODAC meeting for earlier use. With….
0
25
0
RT @FDAOncology: The Spring 2024 FDA-@ASCO Fellows Day Workshop was a great success! We always enjoy meeting talented people at the start o….
0
9
0
Happening now! #Tandem24 Poster reception. Stop by poster #284 to say hello and learn about Mayo Clinic’s outpatient program for #CARTcell and #BsAb. @Radhika_Bansl .@YiLinMDPhD .@jonaspaludo .@MayoCancerCare . #mmsm #lymsm #leuksm @ASTCT.
0
2
11
RT @ChrisGrahamMD: Come by poster #164 at #Tandem24 poster session this evening to learn about patients with silent coronary artery disease….
0
1
0
✈️ Off to San Antonio and ready to kick off #Tandem24. 🤝 Join us at poster #284 on Thursday, 2/22 at 6:45 pm to learn about Mayo Clinic’s outpatient management of #CARTcell & #BsAb. @Radhika_Bansl.@YiLinMDPhD .@jonaspaludo .@MayoCancerCare . @ASTCT @CIBMTR #lymsm #mmsm #leuksm.
1
5
20